What we do
Through our unique process of identifying and understanding the unmet needs of patients, we develop innovative value-added medicines and commercialise them across Europe.
While new medicines are crucial to address untreated diseases, we prioritise developing established molecules into treatment options that improve ease of administration.
Through a blend of patient insight, rigorous data analysis, and dedicated research, we evolve medicines to make them more manageable for patients. Each step of our process is not only what makes us unique, but it contributes to our success and the success of our medicines.
We see the unseen
Our accomplishments are driven by our commitment to actively search for innovative solutions, as we believe that true evolution arises from a combination of data insights and a genuine understanding of patient needs.
By actively listening to healthcare providers and patients, we gain a deep understanding of unmet clinical needs and unseen patient journeys.
We validate the prospective medicine against clinical understanding, engaging with clinicians, clinical pharmacists, prescribers, patients, and professional groups to outline where and how these potentially fit into current treatment regimes. By combining data-driven insights with our extensive knowledge of the disease area and patient experience, we can uncover unique opportunities others might miss from conventional data analysis.
We manage a medicine's journey
Our development strategy for each product is individual; our process is thorough and well-defined. Whatever opportunity arises, once we have identified a product that we can reformulate and add value to, we know the steps required to create a successful, value-added medicine.
Identification:
We identify unique opportunities for value-added medicines. Using a patient-centred approach that goes beyond data analysis, we focus on understanding patients’ experiences, aspirations and the challenges they face.
Development:
Through our innovative process of reformulation and repurposing medicines, we make them more manageable for patients and healthcare professionals, creating solutions that bridge market gaps.
Commercialisation:
We are renowned leaders in commercialising value-added medicines in the UK and across Europe. Through our European platform and our value-aligned partnerships, we amplify impact, expand access, and maximise patient outcomes.
We don't just evolve medicines; we continue to invest
We turn our developments into commercially successful medicines that can meet the needs of patients whose treatment options may have been limited. With an in-depth understanding of the product’s disease area, we actively seek ways to enhance the tolerability and accessibility of these medicines.
We create more manageable medicines for patients and healthcare professionals, and once we have developed a product, we continue to add value. Through our continued investment in research and development, we extend the life cycles of these medicines and continue to develop them for patient’s evolving needs, allowing further expansion into new markets.
From unmet needs to global success
Our success is built on identifying an unmet need and developing an appropriate product formulation, along with our ability to commercialise our medicines to reach patients on a global scale.
Our global reach has been achieved through our close collaboration with value-aligned partners. Our in-depth knowledge and expertise of the disease areas, product development, and commercialisation across our European platform, complemented by our partners’ deep understanding of their local markets and expertise in their respective fields, empowers us to contribute to our collective success.
We diligently identify key opinion leaders, professional bodies, and patient advocacy groups who share our mission. Our goal is to provide the necessary tools and insights, enabling them to drive discussions and bridge information gaps in their markets. Our success hinges on engaging with these groups, listening to their needs, grasping market dynamics, and empowering them through medical education.
We're focused on the future
We are proud to have established ourselves as renowned leaders in value-added medicines.
As a company, we remain dedicated to innovation, continued investment, and supporting unseen and forgotten patient groups to give people a choice to continue their treatment.
